MRI scan to measure prostate acidity before surgery
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new MRI technique that measures acidity in prostate tumors. It may help doctors better understand the cancer before surgery, potentially guiding treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with prostate cancer (confirmed by biopsy).
- Your tumor is at least 1 cm on an MRI or ultrasound, or you have at least 3 positive biopsy cores.
- You are scheduled to have your prostate removed at UCSF within 12 weeks after the study MRI.
- You are generally in good health (able to care for yourself, no serious heart or kidney problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a specialized MRI scan using a pyruvate tracer can better detect high-grade (more aggressive) prostate cancer. It may help doctors find cancer more accurately and guide treatment decisions or targeted follow-up.
This study uses a special MRI scan using “hyperpolarized” labeled pyruvate (a sugar-like substance) to see how prostate cancer may be behaving in people who are on active surveillance. It may help researchers monitor cancer without immediate treatment, by spotting changes earlier.
This trial uses a special MRI scan (with hyperpolarized pyruvate, a naturally occurring substance) to look at prostate cancer in more detail. It aims to help doctors understand how the cancer is responding to treatment or how it might behave.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.